Article Information
- Received June 2, 2006
- Revision received September 21, 2006
- Accepted September 22, 2006
- First published November 1, 2006.
- Version of record published November 1, 2006.
Author Information
- Fabrizio G. Mastronardi1,
- D. Denise Wood1,
- Jiang Mei3,
- Reinout Raijmakers4,
- Vivian Tseveleki5,
- Hans-Michael Dosch2,
- Lesley Probert5,
- Patrizia Casaccia-Bonnefil3, and
- Mario A. Moscarello1
- 1Department of Structural Biology and Biochemistry and
- 2Infection, Immunity, Injury, and Repair, The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8,
- 3Department of Neuroscience and Cell Biology, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854,
- 4Department of Biochemistry, Nijmegen Center for Molecular Life Sciences, Radboud University Nijmegen, NL-6500 HB Nijmegen, The Netherlands, and
- 5Laboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens GR-115 21, Greece
- Correspondence should be addressed to Fabrizio G. Mastronardi, Department of Structural Biology and Biochemistry, The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8. fabrizio{at}sickkids.ca
Author contributions
Disclosures
- Received June 2, 2006.
- Revision received September 21, 2006.
- Accepted September 22, 2006.
-
This work was supported by a research grant from the Multiple Sclerosis Society of Canada (M.A.M., F.G.M.). P.C.-B. was supported by the Multiple Sclerosis Research Foundation, National Multiple Sclerosis Society Grants RG 3421-A-4 and PP1053, and National Institutes of Health–National Institute of Neurological Disorders and Stroke Grant RO1-NS42925. R.R. was supported by Dutch Technology Foundation Grant 790.35.898. H.-M.D. was supported by Canadian Institutes of Health Research. L.P. was supported by 6th Framework Program of the European Union and Neuropromise Grant LSHM-CT-2005-018637. We thank Dr. A. Nicholas (University of Alabama at Birmingham, Birmingham, AL) for the F95 antibody. We thank Teresa Miani for technical support and Michael Ho from the Hematopoietic Stem Cell Immunopathology service laboratory for immunohistochemistry. We are grateful to Drs. R. M. Nagra and W. W. Tourtellotte and their team for providing normal and multiple sclerosis samples from the Human Brain and Spinal Fluid Resource Center's VA West Los Angeles Healthcare Center (Los Angeles, CA), which is sponsored by National Institute of Neurological Disorders and Stroke–National Institute of Mental Health, National Multiple Sclerosis Society, and the Department of Veterans Affairs.
- Correspondence should be addressed to Fabrizio G. Mastronardi, Department of Structural Biology and Biochemistry, The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8. fabrizio{at}sickkids.ca
Online Impact